Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

703
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
703

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

International journal of medical informatics·2026
Same author

Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.

Lancet (London, England)·2026
Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Subgroup analysis in MS trials.

Maria Pia Sormani1

  • 1Biostatistics Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 17, 2016
PubMed
Summary
This summary is machine-generated.

Subgroup analyses in multiple sclerosis (MS) trials are often misleadingly reported. This viewpoint highlights correct reporting methods using interaction tests for accurate interpretation of treatment effects in patient subgroups.

Keywords:
Multiple sclerosissubgroup analysis

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Related Experiment Videos

Last Updated: Mar 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Neurology

Background:

  • Subgroup analyses are post-hoc evaluations in clinical trials to assess treatment effects in specific patient groups.
  • They are used in both positive and negative trials to identify patient subsets with differential treatment benefits or to explore potential efficacy in non-responders.
  • Statistical challenges include multiple testing and underpowered analyses, but reporting and interpretation issues are prominent in multiple sclerosis (MS) studies.

Purpose of the Study:

  • To demonstrate misleading reporting practices of subgroup analyses in MS clinical trials.
  • To advocate for a correct approach to reporting and interpreting subgroup analysis results.
  • To emphasize the importance of interaction tests for valid subgroup evaluations.

Main Methods:

  • Review of common reporting and interpretation methods for subgroup analyses in MS trials.
  • Discussion of statistical challenges, focusing on reporting and interpretation.
  • Presentation of the correct approach using interaction tests.

Main Results:

  • Subgroup analyses in MS trials are frequently reported in ways that can misrepresent treatment effects.
  • Current reporting often fails to account for the statistical complexities and potential for spurious findings.
  • The use of interaction tests is proposed as a statistically sound method for evaluating treatment effects within subgroups.

Conclusions:

  • Misleading reporting of subgroup analyses in MS trials can lead to incorrect conclusions about treatment efficacy.
  • Adoption of interaction tests is crucial for accurate interpretation of subgroup findings.
  • Correct reporting and interpretation are essential for generating reliable hypotheses for future research in MS.